4-Amino-N-(5-ethyl-[1,3,4]thiadiazol-2-yl)-benzenesulfonamide

CAS: 94-19-9

Ref. 3D-AAA09419

Produktinformation

• Name: 4-Amino-N-(5-ethyl-[1,3,4]thiadiazol-2-yl)-benzenesulfonamide
• Synonyme: 2-(p-Aminobenzenesulfamido)-5-ethyl-1,3,4-thiadiazole, 2-(p-Aminobenzenesulfonamido)-5-ethylthiadiazole, 2-(p-Aminophenylsulfonamido)-5-ethyl-1,3,4-thiadiazole, 2-Ethyl-5-sulfanilamido-1,3,4-thiadiazol, 2-Sulfanilamido-5-ethyl-1,3,4-thiadiazole, 2-Sulfanilamido-5-ethylthiadiazole, 4-amino-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide, 5-Sulfanilamido-2-ethyl-1,3,4-thiadiazole, Aethazol, Benzenesulfonamide, 4-amino-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-, Berlophen, Etazol, Etazole, Ethazole, Ethazole (pharmaceutical), Globucid, Globucin, N1-(5-ethyl-1,3,4-thiadiazol-2-yl)sulphanilamide, N¹-(5-Ethyl-1,3,4-thiadiazol-2-yl)sulfanilamide, Sethadil, Sul-Spansion, Sul-Spantab, Sulfa-Perlongit, Sulfaethidiole, Sulfaethidol, Sulfaethylthiadiazole, Sulfanilamide, N¹-(5-ethyl-1,3,4-thiadiazol-2-yl)-, Sulphaethidole, Vk 55

Beschreibung

4-Amino-N-(5-ethyl-[1,3,4]thiadiazol-2-yl)-benzenesulfonamide (ATBS) is an antimicrobial agent that inhibits the growth of bacteria by binding to metal hydroxides in their cell walls. This binding prevents the formation of an antibiotic-inhibitor complex with the enzyme cell wall synthesis that is required for cell wall biosynthesis, inhibiting protein synthesis and cell division. ATBS has been shown to be effective against infectious diseases such as bowel disease and infectious diarrhea. ATBS also has hypoglycemic effects and can be used to treat diabetes mellitus type 2. It may also have a role in treating autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, or Crohn's disease. ATBS is not very soluble in water but is soluble in liquid paraffin and lipids. ATBS is metabolized by p-hyd

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 284.36 g/mol
• Formel: C₁₀H₁₂N₄O₂S₂
• Reinheit: Min. 95%